models:
- models/oncology-sbml-abernathy2016-glioblastoma-treatment-biomd0000000757-model/model.yaml
- models/oncology-sbml-afenya2018-peripheral-blodd-dynamics-in-the-dise-model1910020002-model/model.yaml
- models/oncology-sbml-aghakhani2022-human-breast-cancer-associated-fib-model2307090001-model/model.yaml
- models/oncology-sbml-al-husari2013-ph-and-lactate-in-tumor-biomd0000000805-model/model.yaml
- models/oncology-sbml-al-tuwairqi2020-dynamics-of-cancer-radiovirother-biomd0000001032-model/model.yaml
- models/oncology-sbml-al-tuwairqi2020-dynamics-of-cancer-virotherapy-p-biomd0000001031-model/model.yaml
- models/oncology-sbml-alharbi2019-tumor-normal-model-tnm-of-the-develo-biomd0000001037-model/model.yaml
- models/oncology-sbml-alharbi2019-tumor-normal-vitamins-model-tnvm-of-biomd0000001038-model/model.yaml
- models/oncology-sbml-andersen2017-mathematical-modelling-as-a-proof-o-biomd0000000852-model/model.yaml
- models/oncology-sbml-ayush2018-breast-cancer-detection-using-svm-and-model2407130001-model/model.yaml
- models/oncology-sbml-babbs2012-immunotherapy-biomd0000000758-model/model.yaml
- models/oncology-sbml-bajzer2008-modeling-of-cancer-virotherapy-with-r-biomd0000000771-model/model.yaml
- models/oncology-sbml-barros2021-cartmath-mathematical-model-of-car-t-biomd0000001019-model/model.yaml
- models/oncology-sbml-barros2021-cartmath-mathematical-model-of-car-t-biomd0000001020-model/model.yaml
- models/oncology-sbml-bayleyegn2016-interactions-of-cyce-cdk2-cdc25a-a-model2003180002-model/model.yaml
- models/oncology-sbml-bianconi2012-egfr-and-igf1r-pathway-in-lung-canc-biomd0000000427-model/model.yaml
- models/oncology-sbml-boer1986-interactions-between-macrophages-and-t-model1912110001-model/model.yaml
- models/oncology-sbml-bordel2018-gsmm-for-human-metabolic-reactions-hm-model1707250000-model/model.yaml
- models/oncology-sbml-bouchnita2019-a-multiscale-model-to-design-thera-model1912170004-model/model.yaml
- models/oncology-sbml-bukkuri2022-models-of-mendelian-and-reverse-tran-model2312120001-model/model.yaml
- models/oncology-sbml-capuani2015-human-core-catabolic-network-model1506170000-model/model.yaml
- models/oncology-sbml-celiku-friedenberg-2022-probabilistic-model-chec-model2207180001-model/model.yaml
- models/oncology-sbml-chakrabarty2010-a-control-theory-approach-to-can-biomd0000000777-model/model.yaml
- models/oncology-sbml-chance1960-glycolysis-respiration-biomd0000000281-model/model.yaml
- models/oncology-sbml-chareyron2009-mixed-immunotherapy-and-chemothera-model2001160002-model/model.yaml
- models/oncology-sbml-chaudhury2020-ec50-expansion-and-killing-mathema-biomd0000001025-model/model.yaml
- models/oncology-sbml-chaudhury2020-first-order-expansion-model-of-car-model2109110005-model/model.yaml
- models/oncology-sbml-chaudhury2020-lotka-volterra-mathematical-model-biomd0000001024-model/model.yaml
- models/oncology-sbml-chen2011-1-bone-marrow-invasion-absolute-model-biomd0000000793-model/model.yaml
- models/oncology-sbml-chen2011-2-bone-marrow-invasion-relative-model-biomd0000000795-model/model.yaml
- models/oncology-sbml-claret2009-predicting-phase-iii-overall-survival-model1708310001-model/model.yaml
- models/oncology-sbml-coletti2020-qsp-model-of-prostate-cancer-immunot-model2109110002-model/model.yaml
- models/oncology-sbml-depillis2003-the-dynamics-of-an-optimally-contro-biomd0000000909-model/model.yaml
- models/oncology-sbml-depillis2007-seeking-bang-bang-solutions-of-mixe-model2003060001-model/model.yaml
- models/oncology-sbml-depillis2008-optimal-control-of-mixed-immunother-biomd0000000913-model/model.yaml
- models/oncology-sbml-depillis2013-mathematical-modeling-of-regulatory-biomd0000000908-model/model.yaml
- models/oncology-sbml-dorvash2019-dynamic-modeling-of-signal-transduct-biomd0000000822-model/model.yaml
- models/oncology-sbml-dritschel2018-a-mathematical-model-of-cytotoxic-biomd0000000763-model/model.yaml
- models/oncology-sbml-eftimie2010-immunity-to-melanoma-biomd0000000768-model/model.yaml
- models/oncology-sbml-evans2005-compartmental-model-for-antineoplastic-biomd0000000946-model/model.yaml
- models/oncology-sbml-faratian2009-role-of-pten-in-trastuzumab-resista-biomd0000000424-model/model.yaml
- models/oncology-sbml-fassoni2019-oncogenesis-encompassing-mutations-a-biomd0000000807-model/model.yaml
- models/oncology-sbml-galante2012-b7-h1-and-a-mathematical-model-for-c-biomd0000000812-model/model.yaml
- models/oncology-sbml-gevertz2018-cancer-treatment-with-oncolytic-viru-biomd0000000816-model/model.yaml
- models/oncology-sbml-gevertz2018-cancer-treatment-with-oncolytic-viru-biomd0000000817-model/model.yaml
- models/oncology-sbml-ghaffari2019-thrombomodulin-gene-expression-afte-model1907140001-model/model.yaml
- models/oncology-sbml-giani2019-computational-modeling-to-predict-map3-biomd0000000883-model/model.yaml
- models/oncology-sbml-greene2019-differentiate-spontaneous-and-induced-biomd0000000825-model/model.yaml
- models/oncology-sbml-gulhane2022-sphingolipid-metabolism-and-pi3k-akt-model2402290001-model/model.yaml
- models/oncology-sbml-hayashi2013-extended-tnf-induced-signaling-with-model2502170002-model/model.yaml
- models/oncology-sbml-hayashi2013-tnf-induced-signaling-dynamics-model-model2502170001-model/model.yaml
- models/oncology-sbml-hesse2021-interplay-between-core-clock-and-cance-model2109140001-model/model.yaml
- models/oncology-sbml-hessemuellerrelogio2023-timing-treatment-toxicit-model2305270001-model/model.yaml
- models/oncology-sbml-hu2019-modeling-pancreatic-cancer-dynamics-with-biomd0000000792-model/model.yaml
- models/oncology-sbml-hu2019-pancreatic-cancer-dynamics-biomd0000000744-model/model.yaml
- models/oncology-sbml-hutchinson2016-vascular-phenotype-identification-model1911130007-model/model.yaml
- models/oncology-sbml-iarosz2015-brain-tumor-biomd0000000775-model/model.yaml
- models/oncology-sbml-iwamoto2010-cell-cycle-reponse-to-dna-damage-biomd0000000939-model/model.yaml
- models/oncology-sbml-jafarnejad2019-mechanistically-detailed-systems-model2003200001-model/model.yaml
- models/oncology-sbml-jenner2018-treatment-of-oncolytic-virus-biomd0000000789-model/model.yaml
- models/oncology-sbml-jenner2019-oncolytic-virotherapy-for-tumours-fol-biomd0000000850-model/model.yaml
- models/oncology-sbml-jiao2018-feedback-regulation-in-a-stem-cell-mode-biomd0000000898-model/model.yaml
- models/oncology-sbml-kemmer2022-disentangling-erbb-signaling-in-breas-model2205030001-model/model.yaml
- models/oncology-sbml-khajanchi2015-the-combined-effects-of-optimal-co-biomd0000000897-model/model.yaml
- models/oncology-sbml-kim2007-crosstalk-between-wnt-and-erk-pathways-biomd0000000149-model/model.yaml
- models/oncology-sbml-kimmel2021-t-cell-competition-and-stochastic-ext-biomd0000001041-model/model.yaml
- models/oncology-sbml-kosinsky2018-radiation-and-pd-l-1-treatment-comb-biomd0000000863-model/model.yaml
- models/oncology-sbml-kronik2010-predicting-outcomes-of-prostate-cance-model2001130003-model/model.yaml
- models/oncology-sbml-kuznetsov1994-nonlinear-dynamics-of-immunogenic-biomd0000000762-model/model.yaml
- models/oncology-sbml-l-pez-cort-s2020-prediction-of-breast-cancer-bc-biomd0000001076-model/model.yaml
- models/oncology-sbml-li2016-model-for-pancreatic-cancer-patients-rece-biomd0000000929-model/model.yaml
- models/oncology-sbml-li2021-hdac3i-finder-a-machine-learning-based-co-model2406210001-model/model.yaml
- models/oncology-sbml-lolas2016-tumour-induced-neoneurogenesis-and-per-biomd0000000750-model/model.yaml
- models/oncology-sbml-lombardo2018-expression-of-pdl1-in-neuroblastoma-model1812070002-model/model.yaml
- models/oncology-sbml-lopes2025-nfkb-model-in-breast-cancer-model2508260001-model/model.yaml
- models/oncology-sbml-malinzi2018-enhancement-of-chemotherapy-using-on-model2003050002-model/model.yaml
- models/oncology-sbml-melhem-2017-neutropenia-model-model2211040001-model/model.yaml
- models/oncology-sbml-merola2008-an-insight-into-tumor-dormancy-equili-biomd0000000911-model/model.yaml
- models/oncology-sbml-mkango2019-dynamics-of-breast-cancer-under-diffe-model1912120005-model/model.yaml
- models/oncology-sbml-monro2008-chemotherapy-resistance-biomd0000000776-model/model.yaml
- models/oncology-sbml-moore-2004-mathematical-model-for-cml-and-t-cell-biomd0000000733-model/model.yaml
- models/oncology-sbml-morrison1989-folate-cycle-biomd0000000018-model/model.yaml
- models/oncology-sbml-mpekris2017-role-of-vascular-normalization-in-be-model2001200002-model/model.yaml
- models/oncology-sbml-murphy2016-differences-in-predictions-of-ode-mod-biomd0000000671-model/model.yaml
- models/oncology-sbml-nave2018-prostate-cancer-model-model1910030001-model/model.yaml
- models/oncology-sbml-nazari2018-il6-mediated-stem-cell-driven-tumor-g-biomd0000000819-model/model.yaml
- models/oncology-sbml-nguyen2016-feedback-regulation-in-cell-signallin-biomd0000000651-model/model.yaml
- models/oncology-sbml-nikolaev2019-immunobiochemical-reconstruction-of-biomd0000000865-model/model.yaml
- models/oncology-sbml-ontah2019-dynamic-analysis-of-a-tumor-treatment-biomd0000000877-model/model.yaml
- models/oncology-sbml-orton2009-modelling-cancerous-mutations-in-the-e-biomd0000000623-model/model.yaml
- models/oncology-sbml-owen1998-tumour-growth-model-biomd0000000670-model/model.yaml
- models/oncology-sbml-palaniappan2021-cell-free-modelling-of-second-ge-biomd0000001103-model/model.yaml
- models/oncology-sbml-pappalardo2016-pi3k-akt-and-mapk-signaling-pathw-biomd0000000666-model/model.yaml
- models/oncology-sbml-park2019-cetuximab-resistance-in-colorectal-canc-model1909300004-model/model.yaml
- models/oncology-sbml-perez-garcia19-computational-design-of-improved-biomd0000000814-model/model.yaml
- models/oncology-sbml-raia2010-il13-signalling-medb1-biomd0000000313-model/model.yaml
- models/oncology-sbml-raia2011-il13-l1236-biomd0000000314-model/model.yaml
- models/oncology-sbml-reppas2015-tumor-control-via-alternating-immunos-biomd0000000749-model/model.yaml
- models/oncology-sbml-ribba2012-low-grade-gliomas-tumour-growth-inhibi-biomd0000000521-model/model.yaml
- models/oncology-sbml-ribba2018-mathematical-model-of-tumor-uptake-for-model1909050002-model/model.yaml
- models/oncology-sbml-riya-2024-interplay-between-the-immunologic-netw-model2402030002-model/model.yaml
- models/oncology-sbml-rodrigues2019-a-mathematical-model-for-chemoimmu-biomd0000000879-model/model.yaml
- models/oncology-sbml-rommelfanger2011-generalized-logistic-model-of-m-model2109110004-model/model.yaml
- models/oncology-sbml-rommelfanger2011-gompertz-model-of-melanoma-tumo-model2109110003-model/model.yaml
- models/oncology-sbml-rouhimoghadam2018-gpr30-pi3k-mapk-stat-signaling-model1807040001-model/model.yaml
- models/oncology-sbml-rouhimoghadam2018-gpr30-pi3k-mapk-stat-signaling-model2002250001-model/model.yaml
- models/oncology-sbml-ruscone2023-logical-model-of-tumor-cell-invasion-model2304070002-model/model.yaml
- models/oncology-sbml-schattler2016-dynamical-properties-of-a-minimall-model2002030001-model/model.yaml
- models/oncology-sbml-segun2018-model-of-breast-cancer-determing-chemo-model2003050001-model/model.yaml
- models/oncology-sbml-selvaggio2020-microenvironment-control-of-hybrid-model2004040001-model/model.yaml
- models/oncology-sbml-shariatpanahi2018-mathematical-modeling-of-tumor-model1909090003-model/model.yaml
- models/oncology-sbml-shin-2018-egfr-pyk2-c-met-interaction-network-mo-biomd0000000826-model/model.yaml
- models/oncology-sbml-siddhartha2002-kinetic-modelling-of-cancer-thera-biomd0000001048-model/model.yaml
- models/oncology-sbml-solis-perez2019-a-fractional-mathematical-model-biomd0000000903-model/model.yaml
- models/oncology-sbml-sotolongo-costa2003-behavior-of-tumors-under-non-biomd0000000785-model/model.yaml
- models/oncology-sbml-sun2018-instantaneous-mutation-rate-in-cancer-in-biomd0000000915-model/model.yaml
- models/oncology-sbml-talemi2015-persistent-telomere-associated-dna-da-model1412200000-model/model.yaml
- models/oncology-sbml-tang2019-pharmacology-modelling-of-aurkb-and-zak-biomd0000000940-model/model.yaml
- models/oncology-sbml-taoma2024-the-ssa-based-boolean-model-of-cell-cy-model2405030001-model/model.yaml
- models/oncology-sbml-terfve2012-signalling-in-liver-cancer-logical-mo-model1506260000-model/model.yaml
- models/oncology-sbml-tham2008-pdmodel-tumour-shrinkage-by-gemcitabine-biomd0000000234-model/model.yaml
- models/oncology-sbml-tortolina2015-multiple-signalling-pathway-associ-model1601250000-model/model.yaml
- models/oncology-sbml-unni2019-mathematical-modeling-analysis-and-simu-biomd0000000888-model/model.yaml
- models/oncology-sbml-wei2019-mathematical-modeling-of-tumor-growth-th-model1909090002-model/model.yaml
- models/oncology-sbml-west2019-cellular-interactions-constrain-tumor-g-biomd0000000820-model/model.yaml
- models/oncology-sbml-wodarz2001-viruses-as-antitumor-weapons-biomd0000001043-model/model.yaml
- models/oncology-sbml-wodarz2018-1-simple-model-biomd0000000774-model/model.yaml
- models/oncology-sbml-wodarz2018-2-model-with-transit-amplifying-cells-biomd0000000773-model/model.yaml
- models/oncology-sbml-yang2012-cancer-growth-with-angiogenesis-biomd0000000796-model/model.yaml
- models/oncology-sbml-yangzichen2024-metabolic-machine-learning-predic-model2407230001-model/model.yaml
- models/oncology-sbml-yazdjer2019-reinforcement-learning-based-control-biomd0000000821-model/model.yaml
- models/oncology-sbml-yoon2017-mathematical-modeling-of-mutant-transfe-model1912160006-model/model.yaml
- models/oncology-sbml-zeilfelder2025-model-for-human-liver-cancer-cell-model2503270001-model/model.yaml
- models/oncology-sbml-zhu2015-combined-gemcitabine-and-birinapant-in-p-biomd0000000668-model/model.yaml
- models/oncology-sbml-zhu2015-combined-gemcitabine-and-birinapant-in-p-biomd0000000669-model/model.yaml
spaces:
- spaces/oncology-general-combo-0045/space.yaml
- spaces/oncology-general-combo-0046/space.yaml
- spaces/oncology-general-combo-0047/space.yaml
- spaces/oncology-general-combo-0048/space.yaml
- spaces/oncology-general-combo-0049/space.yaml
- spaces/oncology-general-combo-0054/space.yaml
- spaces/oncology-therapy-response-combo-0050/space.yaml
- spaces/oncology-therapy-response-combo-0051/space.yaml
- spaces/oncology-therapy-response-combo-0052/space.yaml
- spaces/oncology-therapy-response-combo-0053/space.yaml
- spaces/oncology-tumor-growth-combo-0001/space.yaml
- spaces/oncology-tumor-growth-combo-0002/space.yaml
- spaces/oncology-tumor-growth-combo-0003/space.yaml
- spaces/oncology-tumor-growth-combo-0004/space.yaml
- spaces/oncology-tumor-growth-combo-0005/space.yaml
- spaces/oncology-tumor-growth-combo-0006/space.yaml
- spaces/oncology-tumor-growth-combo-0007/space.yaml
- spaces/oncology-tumor-growth-combo-0008/space.yaml
- spaces/oncology-tumor-growth-combo-0009/space.yaml
- spaces/oncology-tumor-growth-combo-0010/space.yaml
- spaces/oncology-tumor-growth-combo-0011/space.yaml
- spaces/oncology-tumor-growth-combo-0012/space.yaml
- spaces/oncology-tumor-growth-combo-0013/space.yaml
- spaces/oncology-tumor-growth-combo-0014/space.yaml
- spaces/oncology-tumor-growth-combo-0015/space.yaml
- spaces/oncology-tumor-growth-combo-0016/space.yaml
- spaces/oncology-tumor-growth-combo-0017/space.yaml
- spaces/oncology-tumor-growth-combo-0018/space.yaml
- spaces/oncology-tumor-growth-combo-0019/space.yaml
- spaces/oncology-tumor-growth-combo-0020/space.yaml
- spaces/oncology-tumor-growth-combo-0021/space.yaml
- spaces/oncology-tumor-growth-combo-0022/space.yaml
- spaces/oncology-tumor-growth-combo-0023/space.yaml
- spaces/oncology-tumor-growth-combo-0024/space.yaml
- spaces/oncology-tumor-growth-combo-0025/space.yaml
- spaces/oncology-tumor-growth-combo-0026/space.yaml
- spaces/oncology-tumor-growth-combo-0027/space.yaml
- spaces/oncology-tumor-growth-combo-0028/space.yaml
- spaces/oncology-tumor-growth-combo-0029/space.yaml
- spaces/oncology-tumor-growth-combo-0030/space.yaml
- spaces/oncology-tumor-growth-combo-0031/space.yaml
- spaces/oncology-tumor-growth-combo-0032/space.yaml
- spaces/oncology-tumor-growth-combo-0033/space.yaml
- spaces/oncology-tumor-growth-combo-0034/space.yaml
- spaces/oncology-tumor-growth-combo-0035/space.yaml
- spaces/oncology-tumor-growth-combo-0036/space.yaml
- spaces/oncology-tumor-growth-combo-0037/space.yaml
- spaces/oncology-tumor-growth-combo-0038/space.yaml
- spaces/oncology-tumor-growth-combo-0039/space.yaml
- spaces/oncology-tumor-growth-combo-0040/space.yaml
- spaces/oncology-tumor-growth-combo-0041/space.yaml
- spaces/oncology-tumor-growth-combo-0042/space.yaml
- spaces/oncology-tumor-growth-combo-0043/space.yaml
- spaces/oncology-tumor-growth-combo-0044/space.yaml
- spaces/oncology-tumor-growth-combo-0055/space.yaml
- spaces/oncology-tumor-growth-combo-0056/space.yaml
- spaces/oncology-tumor-growth-combo-0057/space.yaml
- spaces/oncology-tumor-growth-combo-0058/space.yaml
- spaces/oncology-tumor-growth-combo-0059/space.yaml
- spaces/oncology-tumor-growth-combo-0060/space.yaml
- spaces/oncology-tumor-growth-combo-0061/space.yaml
- spaces/oncology-tumor-growth-combo-0062/space.yaml
- spaces/oncology-tumor-growth-combo-0063/space.yaml
- spaces/oncology-tumor-growth-combo-0064/space.yaml
- spaces/oncology-tumor-growth-combo-0065/space.yaml
- spaces/oncology-tumor-growth-combo-0066/space.yaml
- spaces/oncology-tumor-growth-combo-0067/space.yaml
- spaces/oncology-tumor-growth-combo-0068/space.yaml
- spaces/oncology-tumor-growth-combo-0069/space.yaml
- spaces/oncology-tumor-growth-combo-0070/space.yaml
- spaces/oncology-tumor-growth-combo-0071/space.yaml
- spaces/oncology-tumor-growth-combo-0072/space.yaml
- spaces/oncology-tumor-growth-combo-0073/space.yaml
- spaces/oncology-tumor-growth-combo-0074/space.yaml
- spaces/oncology-tumor-growth-combo-0075/space.yaml
- spaces/oncology-tumor-growth-combo-0076/space.yaml
- spaces/oncology-tumor-growth-combo-0077/space.yaml
- spaces/oncology-tumor-growth-combo-0078/space.yaml
- spaces/oncology-tumor-growth-combo-0079/space.yaml
- spaces/oncology-tumor-growth-combo-0080/space.yaml
